amp(2p24) for Neuroblastoma
CIDEGEN
Delivery time
<1 week
Sample
Biopsy tissue
166,98€
Amplification of the MYCN gene (2p24) is associated with neuroblastoma and medulloblastoma. The level of amplification is related to tumor progression. It is a risk marker in pediatric patients. Its presence is associated with advanced disease. Furthermore, it has also been associated with rhabdomyosarcoma, retinoblastoma, small cell lung carcinoma, and astrocytoma.
Other tests
Trisomy 11 (Blood. Biopsy tissue)
166,98€
Trisomy 11 (Blood. Biopsy tissue. Bone marrow)
166,98€
Sequencing of exons 9, 11, 13 and 14 of the POLE gene. (Analysis in biopsy tissue)
932,31€